Tumor markers of uterine cervical cancer: a new scenario to guide surgical practice?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Denny L (2012) Cervical cancer: prevention and treatment. Discov Med 14:125–131
Vitale SG, Laganà AS, Valenti G, La Rosa VL (2017) Comment on “Laparoscopic myomectomy of a symptomatic uterine leiomyoma in a 15-year-old adolescent”. J Pediatr Adolesc Gynecol 30:442–443. doi: 10.1016/j.jpag.2016.11.013
Laganà AS, Vitale SG, Palmara V, Ban Frangez H, Triolo O (2017) Transvaginal specimen removal in minimally invasive surgery: feasibility and possible complications during the incision of the posterior vaginal wall. World J Urol 35:1155–1156. doi: 10.1007/s00345-016-1955-7
Butticè S, Sener TE, Lucan VC, Lunelli L, Laganà AS, Vitale SG, Netsch C, Tanidir Y, Pappalardo R, Magno C (2017) Hybrid transvaginal NOTES nephrectomy: postoperative sexual outcomes. A three-center matched study. Urology 99:131–135. doi: 10.1016/j.urology.2016.09.023
Laganà AS, Vitale SG, Trovato MA, Palmara VI, Rapisarda AM, Granese R, Sturlese E, De Dominici R, Alecci S, Padula F, Chiofalo B, Grasso R, Cignini P, D’Amico P, Triolo O (2016) Full-thickness excision versus shaving by laparoscopy for intestinal deep infiltrating endometriosis: rationale and potential treatment options. Biomed Res Int 2016:3617179. doi: 10.1155/2016/3617179
Laganà AS, Sapia F, Butticè S, Valenti G, Vitale SG (2016) Comment on “Efficacy and safety of skeletonized mesh implants for advanced pelvic organ prolapse: 12 month follow up”. World J Urol 34:1499–1500. doi: 10.1007/s00345-016-1858-7
Vitale SG, Laganà AS, Rapisarda AM (2016) Letter to the editor: Comment on “Simultaneous treatment of anterior vaginal wall prolapse and stress urinary incontinence by using transobturator four arms polypropylene mesh”. Investig Clin Urol 57:150–151. doi: 10.4111/icu.2016.57.2.150
Vitale SG, Laganà AS, Gulino FA, Tropea A, Tarda S (2016) Prosthetic surgery versus native tissue repair of cystocele: literature review. Updates Surg 68:325–329. doi: 10.1007/s13304-015-0343-y
Di Spiezio Sardo A, Vieira MDC, Laganà AS, Chiofalo B, Vitale SG, Scala M, De Falco M, Nappi C, Catena U, Bifulco G (2017) Combined systemic and hysteroscopic intra-amniotic injection of methotrexate associated with hysteroscopic resection for cervical pregnancy: a cutting-edge approach for an uncommon condition. Eurasian J Med 49:66–68. doi: 10.5152/eurasianjmed.2017.16215
Butticè S, Laganà AS, Mucciardi G, Marson F, Tefik T, Netsch C, Vitale SG, Sener E, Pappalardo R, Magno C (2016) Different patterns of pelvic ureteral endometriosis. What is the best treatment? Results of a retrospective analysis. Arch Ital Urol Androl 88:266–269. doi: 10.4081/aiua.2016.4.266
Laganà AS, Vitale SG, Muscia V, Rossetti P, Buscema M, Triolo O, Rapisarda AM, Giunta L, Palmara V, Granese R, Frangez HB, Romano A (2017) Endometrial preparation with Dienogest before hysteroscopic surgery: a systematic review. Arch Gynecol Obstet 295:661–667. doi: 10.1007/s00404-016-4244-1
Laganà AS, Giacobbe V, Triolo O, Granese R, Ban Frangez H, Vrtacnik-Bokal E, Ietto C, Palmara VI (2016) Dienogest as preoperative treatment of submucous myomas for hysteroscopic surgery: a prospective, randomized study. Gynecol Endocrinol 32:408–411. doi: 10.3109/09513590.2015.1128409
Laganà AS, Santoro G, Triolo O, Giacobbe V, Certo R, Palmara V (2015) Hashimoto thyroiditis onset after laparoscopic removal of struma ovarii: an overview to unravel a rare and intriguing finding. Clin Exp Obstet Gynecol 42:673–678
Laganà AS, Sofo V, Salmeri FM, Palmara VI, Triolo O, Terzic MM, Patrelli TS, Lukanovic A, Bokal EV, Santoro G (2016) Oxidative stress during ovarian torsion in pediatric and adolescent patients: changing the perspective of the disease. Int J Fertil Steril 9:416–423
Laganà AS, Vitale SG, De Dominici R, Padula F, Rapisarda AM, Biondi A, Cianci S, Valenti G, Capriglione S, Frangez HB, Sturlese E (2016) Fertility outcome after laparoscopic salpingostomy or salpingectomy for tubal ectopic pregnancy A 12-years retrospective cohort study. Ann Ital Chir 87:461–465
Vitale SG, Gasbarro N, Laganà AS, Sapia F, Rapisarda AMC, Valenti G, Trovato MA, Rossetti D, Chiofalo B, Barrasso G, Tinelli A, Corrado F (2016) Safe introduction of ancillary trocars in gynecological surgery: the “yellow island” anatomical landmark. Ann Ital Chir 87:608–611
Giacobbe V, Rossetti D, Vitale SG, Rapisarda AM, Padula F, Laganà AS, Palmara VI (2016) Otorrhagia and nosebleed as first signs of intravascular absorption syndrome during hysteroscopy: from bench to bedside. Kathmandu Univ Med J (KUMJ) 14:87–89
Laganà AS, Colonese F, Colonese E, Sofo V, Salmeri FM, Granese R, Chiofalo B, Ciancimino L, Triolo O (2015) Cytogenetic analysis of epithelial ovarian cancer’s stem cells: an overview on new diagnostic and therapeutic perspectives. Eur J Gynaecol Oncol 36:495–505
Bellia A, Vitale SG, Laganà AS, Cannone F, Houvenaeghel G, Rua S, Ladaique A, Jauffret C, Ettore G, Lambaudie E (2016) Feasibility and surgical outcomes of conventional and robot-assisted laparoscopy for early-stage ovarian cancer: a retrospective, multicenter analysis. Arch Gynecol Obstet 294:615–622. doi: 10.1007/s00404-016-4087-9
Vitale SG, Marilli I, Lodato M, Tropea A, Cianci A (2013) The role of cytoreductive surgery in advanced-stage ovarian cancer: a systematic review. Updates Surg 65:265–270. doi: 10.1007/s13304-013-0213-4
Laganà AS, Sofo V, Vitale SG, Triolo O (2016) Epithelial ovarian cancer inherent resistance: may the pleiotropic interaction between reduced immunosurveillance and drug-resistant cells play a key role? Gynecol Oncol Rep 18:57–58. doi: 10.1016/j.gore.2016.09.004
Vitale SG, Valenti G, Gulino FA, Cignini P, Biondi A (2016) Surgical treatment of high stage endometrial cancer: current perspectives. Updates Surg 68:149–154. doi: 10.1007/s13304-015-0340-1
Rossetti D, Bogani G, Carnelli M, Vitale SG, Grosso G, Frigerio L (2014) Efficacy of IVF following conservative management of endometrial cancer. Gynecol Endocrinol 30:280–281. doi: 10.3109/09513590.2014.892065
Vitale SG, Rossetti D, Tropea A, Biondi A, Laganà AS (2017) Fertility sparing surgery for stage IA type I and G2 endometrial cancer in reproductive-aged patients: evidence-based approach and future perspectives. Updates Surg 69:29–34. doi: 10.1007/s13304-017-0419-y
Cignini P, Vitale SG, Laganà AS, Biondi A, La Rosa VL, Cutillo G (2017) Preoperative work-up for definition of lymph node risk involvement in early stage endometrial cancer: 5-year follow-up. Updates Surg 69:75–82. doi: 10.1007/s13304-017-0418-z
Vitale SG, Valenti G, Biondi A, Rossetti D, Frigerio L (2015) Recent trends in surgical and reconstructive management of vulvar cancer: review of literature. Updates Surg 67:367–371. doi: 10.1007/s13304-015-0303-6
Benard VB, Thomas CC, King J, Massetti GM, Doria-Rose VP, Saraiya M, Centers for Disease C, Prevention (2014) Vital signs: cervical cancer incidence, mortality, and screening—United States, 2007–2012. MMWR Morb Mortal Wkly Rep 63:1004–1009
Laganà AS, La Rosa V, Petrosino B, Vitale SG (2017) Comment on “Risk of developing major depression and anxiety disorders among women with endometriosis: a longitudinal follow-up study”. J Affect Disord 208:672–673. doi: 10.1016/j.jad.2016.07.016
Vitale SG, La Rosa VL, Rapisarda AM, Laganà AS (2017) Comment on: “Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference”. J Psychosom Obstet Gynaecol 38:81–82. doi: 10.1080/0167482X.2016.1244183
Vitale SG, La Rosa VL, Rapisarda AM, Laganà AS (2016) Impact of endometriosis on quality of life and psychological well-being. J Psychosom Obstet Gynaecol 18:1–3. doi: 10.1080/0167482X.2016.1244185
Laganà AS, La Rosa VL, Rapisarda AM, Vitale SG (2017) Comment on: “Needs and priorities of women with endometrial and cervical cancer”. J Psychosom Obstet Gynaecol 38:85–86. doi: 10.1080/0167482X.2016.1244186
Vitale SG, La Rosa VL, Rapisarda AM, Laganà AS (2017) Comment on: “Anxiety and depression in patients with advanced ovarian cancer: a prospective study”. J Psychosom Obstet Gynaecol 38:83–84. doi: 10.1080/0167482X.2016.1244182
Vitale SG, La Rosa VL, Rapisarda AM, Laganà AS (2017) Psychology of infertility and assisted reproductive treatment: the Italian situation. J Psychosom Obstet Gynaecol 38:1–3. doi: 10.1080/0167482X.2016.1244184
Vitale SG, Petrosino B, La Rosa VL, Laganà AS (2017) Comment on “Differences in psychophysical well-being and signs of depression in couples undergoing their first consultation for assisted reproduction technology (ART): an Italian pilot study”. Eur J Obstet Gynecol Reprod Biol 211:210–211. doi: 10.1016/j.ejogrb.2016.10.029
Laganà AS, La Rosa VL, Rapisarda AM, Vitale SG (2017) Comment on: “Effect on sexual function of patients and patients’ spouses after midurethal sling procedure for stress urinary incontinence: a prospective single center study”. Low Urin Tract Symptoms 9:62. doi: 10.1111/luts.12164
Vitale SG, Petrosino B, La Rosa VL, Rapisarda AM, Laganà AS (2016) A systematic review of the association between psychiatric disturbances and endometriosis. J Obstet Gynaecol Can 38:1079–1080. doi: 10.1016/j.jogc.2016.09.008
Muscatello MR, Lorusso S, Bruno A, Reale R, Ciura GL, Laganà AS, Retto G, Sturlese E, Zoccali RA (2016) Anger in women treated with assisted reproductive technology (ART): effects on mother and newborn. J Matern Fetal Neonatal Med 29:813–817. doi: 10.3109/14767058.2015.1019459
Laganà AS, Condemi I, Retto G, Muscatello MR, Bruno A, Zoccali RA, Triolo O, Cedro C (2015) Analysis of psychopathological comorbidity behind the common symptoms and signs of endometriosis. Eur J Obstet Gynecol Reprod Biol 194:30–33. doi: 10.1016/j.ejogrb.2015.08.015
Vitale SG, La Rosa VL, Rapisarda AM, Laganà AS (2016) Comment on: “The consequences of gynaecological cancer in patients and their partners from the sexual and psychological perspective”. Prz Menopauzalny 15:186–187. doi: 10.5114/pm.2016.63501
Laganà AS, La Rosa VL, Rapisarda AM, Platania A, Vitale SG (2017) Psychological impact of fertility preservation techniques in women with gynaecological cancer. Ecancermedicalscience 11:ed62. doi: 10.3332/ecancer.2017.ed62
Ferranti G, Prosperi Porta R, La Rosa VL, Vitale SG, Laganà AS (2017) Reflections on treatments for infertility and the possible occurrence of ovarian carcinomas. Recent Prog Med 108:136–140. doi: 10.1701/2656.27236
Perkins AC, Skinner EN (2016) A review of the current cervical cancer screening guidelines. N C Med J 77:420–422. doi: 10.18043/ncm.77.6.420
Zhang HS, Postigo AA, Dean DC (1999) Active transcriptional repression by the Rb–E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition. Cell 97(53–6):1
Volgareva G, Zavalishina L, Andreeva Y, Frank G, Krutikova E, Golovina D, Bliev A, Spitkovsky D, Ermilova V, Kisseljov F (2004) Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells. BMC Cancer 4:58. doi: 10.1186/1471-2407-4-58
Vitale SG, Valenti G, Rapisarda AMC, Calì I, Marilli I, Zigarelli M, Sarpietro G, Cianci A (2016) P16INK4a as a progression/regression tumour marker in LSIL cervix lesions: our clinical experience. Eur J Gynaecol Oncol 37:685–688
Bergeron C, Ikenberg H, Sideri M, Denton K, Bogers J, Schmidt D, Alameda F, Keller T, Rehm S, Ridder R, Group PS (2015) Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results. Cancer Cytopathol 123:373–381. doi: 10.1002/cncy.21542
Carcopino X, Henry M, Mancini J, Giusiano S, Boubli L, Olive D, Tamalet C (2012) Significance of HPV 16 and 18 viral load quantitation in women referred for colposcopy. J Med Virol 84:306–313. doi: 10.1002/jmv.23190
Haedicke J, Iftner T (2016) A review of the clinical performance of the Aptima HPV assay. J Clin Virol 76(Suppl 1):S40–S48. doi: 10.1016/j.jcv.2015.10.027
Cattani P, Zannoni GF, Ricci C, D’Onghia S, Trivellizzi IN, Di Franco A, Vellone VG, Durante M, Fadda G, Scambia G, Capelli G, De Vincenzo R (2009) Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. J Clin Microbiol 47:3895–3901. doi: 10.1128/JCM.01275-09
Frega A, Sesti F, Lombardi D, Votano S, Sopracordevole F, Catalano A, Milazzo GN, Lombardo R, Assorgi C, Olivola S, Chiusuri V, Ricciardi E, French D, Moscarini M (2014) Assessment of HPV-mRNA test to predict recurrent disease in patients previously treated for CIN 2/3. J Clin Virol 60:39–43. doi: 10.1016/j.jcv.2014.01.017
Demirel D, Akyurek N, Ramzy I (2013) Diagnostic and prognostic significance of image cytometric DNA ploidy measurement in cytological samples of cervical squamous intraepithelial lesions. Cytopathology 24:105–112. doi: 10.1111/cyt.12039
David O, Cabay RJ, Pasha S, Dietrich R, Leach L, Guo M, Mehrotra S (2009) The role of deeper levels and ancillary studies (p16(Ink4a) and ProExC) in reducing the discordance rate of Papanicolaou findings of high-grade squamous intraepithelial lesion and follow-up cervical biopsies. Cancer 117:157–166. doi: 10.1002/cncy.20020
Rodolakis A, Biliatis I, Symiakaki H, Kershnar E, Kilpatrick MW, Haidopoulos D, Thomakos N, Antsaklis A (2012) Role of chromosome 3q26 gain in predicting progression of cervical dysplasia. Int J Gynecol Cancer 22:742–747. doi: 10.1097/IGC.0b013e31825104bd
Liu P, Iden M, Fye S, Huang YW, Hopp E, Chu C, Lu Y, Rader JS (2017) Targeted, deep sequencing reveals full methylation profiles of multiple HPV types and potential biomarkers for cervical cancer progression. Cancer Epidemiol Biomark Prev 26:642–650. doi: 10.1158/1055-9965.EPI-16-0368
Bhat S, Kabekkodu SP, Noronha A, Satyamoorthy K (2016) Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer. Biochimie 121:298–311. doi: 10.1016/j.biochi.2015.12.018
Vetvicka V, Laganà AS, Salmeri FM, Triolo O, Palmara VI, Vitale SG, Sofo V, Kralickova M (2016) Regulation of apoptotic pathways during endometriosis: from the molecular basis to the future perspectives. Arch Gynecol Obstet 294:897–904. doi: 10.1007/s00404-016-4195-6
Laganà AS, Salmeri FM, Triolo O, Vitale SG, Granese R, Sofo V (2016) Comments on “rhTNFR: Fc suppresses the development of endometriosis in a mouse model by downregulating cell proliferation and invasiveness”. Reprod Sci. doi: 10.1177/1933719116653838
Maniglio P, Ricciardi E, Laganà AS, Triolo O, Caserta D (2016) Epigenetic modifications of primordial reproductive tract: a common etiologic pathway for Mayer–Rokitansky–Kuster–Hauser syndrome and endometriosis? Med Hypotheses 90:4–5. doi: 10.1016/j.mehy.2016.02.015
Laganà AS, Triolo O, Salmeri FM, Granese R, Palmara VI, Ban Frangez H, Vrtcnik Bokal E, Sofo V (2016) Natural Killer T cell subsets in eutopic and ectopic endometrium: a fresh look to a busy corner. Arch Gynecol Obstet 293:941–949. doi: 10.1007/s00404-015-4004-7
Sofo V, Gotte M, Laganà AS, Salmeri FM, Triolo O, Sturlese E, Retto G, Alfa M, Granese R, Abrao MS (2015) Correlation between dioxin and endometriosis: an epigenetic route to unravel the pathogenesis of the disease. Arch Gynecol Obstet 292:973–986. doi: 10.1007/s00404-015-3739-5
Salmeri FM, Laganà AS, Sofo V, Triolo O, Sturlese E, Retto G, Pizzo A, D’Ascola A, Campo S (2015) Behavior of tumor necrosis factor-alpha and tumor necrosis factor receptor 1/tumor necrosis factor receptor 2 system in mononuclear cells recovered from peritoneal fluid of women with endometriosis at different stages. Reprod Sci 22:165–172. doi: 10.1177/1933719114536472
Sturlese E, Salmeri FM, Retto G, Pizzo A, De Dominici R, Ardita FV, Borrielli I, Licata N, Laganà AS, Sofo V (2011) Dysregulation of the Fas/FasL system in mononuclear cells recovered from peritoneal fluid of women with endometriosis. J Reprod Immunol 92:74–81. doi: 10.1016/j.jri.2011.08.005
Laganà AS, Salmeri FM, Vitale SG, Triolo O, Gotte M (2017) Stem cell trafficking during endometriosis. Reprod Sci. doi: 10.1177/1933719116687661
Kruszyna L, Lianeri M, Roszak A, Jagodzinski PP (2010) HER2 codon 655 polymorphism is associated with advanced uterine cervical carcinoma. Clin Biochem 43:545–548. doi: 10.1016/j.clinbiochem.2009.12.016
Sousa H, Oliveira S, Santos AM, Catarino R, Moutinho J, Medeiros R (2014) Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancer. Tumour Biol 35:2561–2564. doi: 10.1007/s13277-013-1337-3
Yeasmin S, Nakayama K, Rahman MT, Rahman M, Ishikawa M, Iida K, Otsuki Y, Kobayashi H, Nakayama S, Miyazaki K (2010) Expression of nuclear Notch3 in cervical squamous cell carcinomas and its association with adverse clinical outcomes. Gynecol Oncol 117:409–416. doi: 10.1016/j.ygyno.2010.03.004
Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G (2000) Overexpression of hypoxia-inducible factor1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 60:4693–4696
Tanaka T, Terai Y, Kogata Y, Ashihara K, Maeda K, Fujiwara S, Yoo S, Tanaka Y, Tsunetoh S, Sasaki H, Kanemura M, Tanabe A, Ohmichi M (2015) CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer. Oncol Rep 34:2282–2288. doi: 10.3892/or.2015.4257
Landt S, Jeschke S, Koeninger A, Thomas A, Heusner T, Korlach S, Ulm K, Schmidt P, Blohmer JU, Lichtenegger W, Sehouli J, Kuemmel S (2010) Tumor-specific correlation of tumor M2 pyruvate kinase in pre-invasive, invasive and recurrent cervical cancer. Anticancer Res 30:375–381